| NDC Code | 70436-025-80 |
|---|
| Package Description | 1 INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION in 1 VIAL, SINGLE-DOSE (70436-025-80) |
|---|
| Product NDC | 70436-025 |
|---|
| Product Type Name | HUMAN PRESCRIPTION DRUG |
|---|
| Proprietary Name | Bivalirudin |
|---|
| Non-Proprietary Name | Bivalirudin |
|---|
| Dosage Form | INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION |
|---|
| Usage | INTRAVENOUS |
|---|
| Start Marketing Date | 20210630 |
|---|
| Marketing Category Name | ANDA |
|---|
| Application Number | ANDA213078 |
|---|
| Manufacturer | Slate Run Pharmaceuticals, LLC |
|---|
| Substance Name | BIVALIRUDIN |
|---|
| Strength | 250 |
|---|
| Strength Unit | mg/1 |
|---|
| Pharmacy Classes | Anti-coagulant [EPC], Direct Thrombin Inhibitor [EPC], Thrombin Inhibitors [MoA] |
|---|